Ex vivo expansion of umbilical cord blood

Cytotherapy

Volumn 7, Issue 3, 2005, Pages 243-250

  Robinson, S ^a   Niu, T ^a   de Lima, M ^a   Ng, J ^a   Yang, H ^a   McMannis, J ^a   Karandish, S ^a   Sadeghi, T ^a   Fu, P ^a   de Angel, M ^a   O'Connor, S ^a   Champlin, R ^a   Shpall, Elizabeth J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Continuous perfusion; Cord Blood; Ex vivo expansion; Liquid culture; Mesenchymal stem cells (MSC); MSC co culture

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; GROWTH FACTOR;

CELL COUNT; CELL CULTURE; CELL PROLIFERATION; CELL RENEWAL; COCULTURE; CORD BLOOD STEM CELL TRANSPLANTATION; EX VIVO EXPANSION; EX VIVO STUDY; GRAFT FAILURE; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYME CELL; NEUTROPENIA; REVIEW; THROMBOCYTOPENIA; TISSUE EXPANSION; UMBILICAL CORD BLOOD;

EID: 22944442616     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/14653240510027172     Document Type: Article

References (103)

1. Broxmeyer HE, Hangoc G, Cooper S et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA 1992;89:4109-13.
2. Cohen Y, Kreiser D, Mayorov M et al. Unrelated and related cord blood banking and hematopoietic graft engineering. Cell Tissue Bank 2003;4:29-35.
3. Cohen Y, Nagler A. Umbilical cord blood transplantation: how, when and for whom? Blood Rev 2004;18:167-79.
4. Kurtzberg J, Laughlin M, Graham ML et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-66.
5. Broxmeyer HE, Gluckman E, Auerbach A et al. Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. Int J Cell Cloning 1990;8(suppl 1):76-89.
6. Broxmeyer HE, Douglas GW, Hangoc G et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989;86:3828-32.
7. Laughlin MJ, Barker J, Bambach B et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001;344:1815-22.
8. Migliaccio AR, Adamson JW, Stevens CE et al. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000;96:2717-22.
9. Gluckman E, Rocha V, Chevret S. Results of unrelated umbilical cord blood hematopoietic stem cell transplantation. Rev Clin Exp Hematol 2001;5:87-99.
10. Gluckman E, Rocha V, Arcese W et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004;32:397-407.
11. Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-77.
12. Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997;337:373-81.
13. Weinreb S, Delgado JC, Clavijo OP et al. Transplantation of unrelated cord blood cells. Bone Marrow Transplant 1998;22: 193-6.
14. Barker JN, Weisdorf DJ, Wagner JE. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 2001;344:1870-1.
15. Barker JN, Weisdorf DJ, Defor TE et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003;102:1915-9.
16. de Lima M, St John LS, Wieder ED et al. Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units. Br J Haematol 2002;119: 773-6.
17. Fernandez MN, Regidor C, Cabrera R et al. Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms. Bone Marrow Transplant 2001;28:355-63.
18. Shpall EJ, Quinones R, Giller R et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002;8:368-76.
19. Pecora AL, Stiff P, Jennis A et al. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant 2000;25:797-9.
20. Jaroscak J, Goltry K, Smith A et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase I trial using the AastromReplicell System. Blood 2003;101:5061-7.
21. Pecora AL, Stiff P, LeMaistre CF et al. A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation. Bone Marrow Transplant 2001;28:295-303.
22. McNiece I, Jones R, Bearman SI et al. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 2000;96:3001-7.
23. McNiece I, Jones R, Cagnoni P et al. Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer. Hematol Cell Ther 1999;41:82-6.
24. Purdy MH, Hogan CJ, Hami L et al. Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantation. J Hematother 1995;4:515-25.
25. Guenechea G, Gan OI, Dorrell C et al. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat Immunol 2001;2:75-82.
26. Lemischka IR, Jordan CT. The return of clonal marking sheds new light on human hematopoietic stem cells. Nat Immunol 2001;2:11-2.
27. + cord blood cells transplanted into NOD/SCID mice. Proc Natl Acad Sci USA 2002;99:413-8.
28. + G0 cells from cord blood show a high incidence of long-term culture-initiating cells and a capacity for more than 100 million-fold amplification of colony-forming cells in vitro. Stem Cells 2004;22:704-15.
29. + cells. Stem Cells 2001;19:505-13.
30. Williams DA. Ex vivo expansion of hematopoietic stem and progenitor cells: robbing Peter to pay Paul? Blood 1993;81: 3169-72.
31. McNiece IK, Almeida-Porada G, Shpall EJ et al. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp Hematol 2002;30:612-6.
32. Von Drygalski A, Alespeiti G, Ren L et al. Murine bone marrow cells cultured ex vivo in the presence of multiple cytokine combinations lose radioprotective and long-term engraftment potential. Stem Cells Dev 2004;13:101-11.
33. Holyoake TL, Alcorn MJ, Richmond L et al. CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative, chemoradiotherapy regimens. Bone Marrow Transplant 1997;19:1095-101.
34. Piacibello W, Sanavio F, Severino A et al. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood 1999;93:3736-49.
35. Lewis ID, Almeida-Porada G, Du J et al. Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system. Blood 2001;97:3441-9.
36. Guenechea G, Segovia JC, Albella B et al. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells. Blood 1999;93:1097-105.
37. Zhai QL, Qiu LG, Li Q et al. Short-term ex vivo expansion sustains the homing-related properties of umbilical cord blood hematopoietic stem and progenitor cells. Haematologica 2004;89: 265-73.
38. Glimm H, Oh IH, Eaves CJ. Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0). Blood 2000;96:4185-93.
39. Glimm H, Eaves CJ. Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture. Blood 1999;94:2161-8.
40. Gammaitoni L, Weisel KC, Gunetti M et al. Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication. Blood 2004;103:4440-8.
41. Piacibello W, Sanavio F, Garetto L et al. The role of c-Mpl ligands in the expansion of cord blood hematopoietic progenitors. Stem Cells 1998;16(suppl 2):243-8.
42. Piacibello W, Sanavio F, Severino A et al. Ex vivo expansion of cord blood progenitors. Vox Sang 1998;74(suppl 2):457-62.
43. + cells into rapid division. Exp Hematol 1999; 27:1019-28.
44. + Lin-primitive progenitor cells. Blood 1996;88:1619-31.
45. Lazzari L, Lucchi S, Montemurro T et al. Evaluation of the effect of cryopreservation on ex vivo expansion of hematopoietic progenitors from cord blood. Bone Marrow Transplant 2001;28:693-8.
46. Lazzari L, Lucchi S, Porretti L et al. Comparison of different serum-free media for ex vivo expansion of HPCs from cord blood using thrombopoietin, Flt-3 ligand, IL-6, and IL-11. Transfusion 2001;41:718-9.
47. Lazzari L, Lucchi S, Rebulla P et al. Long-term expansion and maintenance of cord blood haematopoietic stem cells using thrombopoietin, Flt3-ligand, interleukin (IL)-6 and IL-11 in a serum-free and stroma-free culture system. Br J Haematol 2001;112:397-404.
48. + cells selected from high-risk breast cancer patients. Neoplasma 2000;47:73-80.
49. +-selected autologous peripheral blood progenitor cells (PBPC) in high-risk breast cancer patients receiving intensive chemotherapy. Hematol Cell Ther 1999; 41: 105-12.
50. McNiece I, Kubegov D, Kerzic P et al. Increased expansion and differentiation of cord blood products using a two-step expansion culture. Exp Hematol 2000;28:1181-6.
51. Piacibello W, Sanavio F, Garetto L et al. Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation. Leukemia 1998;12:718-27.
52. Yao CL, Chu IM, Hsieh TB et al. A systematic strategy to optimize ex vivo expansion medium for human hematopoietic stem cells derived from umbilical cord blood mononuclear cells. Exp Hematol 2004;32:720-7.
53. + cells and increases their engraftment potential in NOD/SCID mice. Exp Hematol 2004; 32:547-55.
54. Peled T, Mandel J, Goudsmid NR et al. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. Cytotherapy 2004;6:344-55.
55. + cells. Br J Haematol 2002; 116:655-61.
56. Young JC, Wu S, Hansteen G et al. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal. Cytotherapy 2004;6:328-36.
57. Sato N, Meijer L, Skaltsounis L et al. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 2004;10:55-63.
58. Schofield R. The stem cell system. Biomed Pharmacother 1983;37:375-80.
59. Lemischka IR, Moore KA. Stem cells: interactive niches. Nature 2003;425:778-9.
60. Fuchs E, Tumbar T, Guasch G. Socializing with the neighbors: stem cells and their niche. Cell 2004;116:769-78.
61. Allen TD, Dexter TM. The essential cells of the hemopoietic microenvironment. Exp Hematol 1984;12:517-21.
62. Allen TD, Simons PJ, Dexter TM. Haemopoietic microenvironments in vitro: which cells are involved? Blood Cells 1984;10: 467-71.
63. Chang J, Allen TD, Dexter TM. Long-term bone marrow cultures: their use in autologous marrow transplantation. Cancer Cells 1989;1:17-24.
64. Dexter TM, Allen TD, Lajtha LG et al. Stimulation of differentiation and proliferation of haemopoietic cells in vitro. J Cell Physiol 1973;82:461-73.
65. Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 1977;91:335-44.
66. Dexter TM, Coutinho LH, Spooncer E et al. Stromal cells in haemopoiesis. Ciba Found Symp 1990;148:76-86.
67. Moore MA, Sheridan AP, Allen TD et al. Prolonged hematopoiesis in a primate bone marrow culture system: characteristics of stem cell production and the hematopoietic microenvironment. Blood 1979;54:775-93.
68. Roberts RA, Spooncer E, Parkinson EK et al. Metabolically inactive 3T3 cells can substitute for marrow stromal cells to promote the proliferation and development of multipotent haemopoietic stem cells. J Cell Physiol 1987;132: 203-14.
69. Yamazaki K, Roberts RA, Spooncer E et al. Cellular interactions between 3T3 cells and interleukin-3-dependent multipotent haemopoietic cells: a model system for stromal-cell-mediated haemopoiesis. J Cell Physiol 1989;139:301-12.
70. Gartner S, Kaplan HS. Long-term culture of human bone marrow cells. Proc Natl Acad Sci USA 1980;77:4756-9.
71. Hackney JA, Charbord P, Brunk BP et al. A molecular profile of a hematopoietic stem cell niche. Proc Natl Acad Sci USA 2002;99:13061-6.
72. Etheridge SL, Spencer GJ, Heath DJ et al. Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 2004;22:849-60.
73. Kadereit S, Deeds LS, Haynesworth SE et al. Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)/CD38(-) early progenitors cultured over human MSCs as a feeder layer. Stem Cells 2002;20:573-82.
74. Rattis FM, Voermans C, Reya T. Wnt signaling in the stem cell niche. Curr Opin Hematol 2004;11:88-94.
75. Zhang J, Niu C, Ye L et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003;425: 836-41.
76. Majumdar MK, Thiede MA, Haynesworth SE et al. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 2000;9:841-8.
77. Majumdar MK, Thiede MA, Mosca JD et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998;176:57-66.
78. + cells. Exp Hematol 2004;32:657-64.
79. Yamaguchi M, Hirayama F, Wakamoto S et al. Bone marrow stromal cells prepared using AB serum and bFGF for hematopoietic stem cells expansion. Transfusion 2002;42:921-7.
80. Yamaguchi M, Hirayama F, Murahashi H et al. Ex vivo expansion of human UC blood primitive hematopoietic progenitors and transplantable stem cells using human primary BM stromal cells and human AB serum. Cytotherapy 2002;4: 109-18.
81. Yamaguchi M, Hirayama F, Kanai M et al. Serum-free coculture system for ex vivo expansion of human cord blood primitive progenitors and SCID mouse-reconstituting cells using human bone marrow primary stromal cells. Exp Hematol 2001;29:174-82.
82. Kanai M, Hirayama F, Yamaguchi M et al. Stromal cell-dependent ex vivo expansion of human cord blood progenitors and augmentation of transplantable stem cell activity. Bone Marrow Transplant 2000;26:837-44.
83. McNiece I, Harrington J, Turney J et al. Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. Cytotherapy 2004;6:311-7.
84. in't Anker PS, Noort WA, Kruisselbrink AB et al. Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 2003;31: 881-9.
85. in't Anker PS, Noort WA, Scherjon SA et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 2003;88:845-52.
86. in't Anker PS, Scherjon SA, Kleijburg-van der Keur C et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003;102:1548-9.
87. Ahrens N, Tormin A, Paulus M et al. Mesenchymal stem cell content of human vertebral bone marrow. Transplantation 2004;78:925-9.
88. Wexler SA, Donaldson C, Denning-Kendall P et al. Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol 2003;121:368-74.
89. Noort WA, Kruisselbrink AB, in't Anker PS et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 2002;30:870-8.
90. Le Blanc K, Rasmusson I, Gotherstrom C et al. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand J Immunol 2004;60:307-15.
91. Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-41.
92. Gotherstrom C, Ringden O, Tammik C et al. Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 2004;190:239-45.
93. Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 2003;5:485-9.
94. Rasmusson I, Ringden O, Sundberg B et al. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003;76:1208-13.
95. Le Blanc K, Tammik C, Rosendahl K et al. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003;31:890-6.
96. Gotherstrom C, Ringden O, Westgren M et al. Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells. Bone Marrow Transplant 2003;32:265-72.
97. Le Blanc K, Tammik L, Sundberg B et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003;57:11-20.
98. De Angeli S, Di Liddo R, Buoro S et al. New immortalized human stromal cell lines enhancing in vitro expansion of cord blood hematopoietic stem cells. Int J Mol Med 2004;13:363-71.
99. Emerson SG, Palsson BO, Clarke MF et al. In vitro expansion of hematopoietic cells for clinical application. Cancer Treat Res 1995;76:215-23.
100. Van Zant G, Rummel SA, Koller MR et al. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood. Blood Cells 1994;20:482-90.
101. Koller MR, Emerson SG, Palsson BO. Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood 1993;82: 378-84.
102. Koller MR, Manchel I, Newsom BS et al. Bioreactor expansion of human bone marrow: comparison of unprocessed, density-separated, and CD34-enriched cells. J Hematother 1995;4:159-69.
103. Koller MR, Manchel I, Maher RJ et al. Clinical-scale human umbilical cord blood cell expansion in a novel automated perfusion culture system. Bone Marrow Transplant 1998;21: 653-63.